Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 14.97B |
| Enterprise Value | 11.53B |
| P/E Ratio | 24.86 |
| PEG Ratio | -0.97 |
| Price/Sales Ratio | 2.16 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 1.7 |
| Enterprise/EBITDA | 13.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.05 |
| Return On Assets | 0.05 |
| Return On Equity | 0.07 |
| Revenue | 6.4B |
| Revenue/Share | 122.64 |
| Gross Profit | 3.48B |
| EBITDA | 724M |
| Net Income | 923M |
| Diluted EPS | 18.37 |
| Total Cash | 3.83B |
| Total Cash/Share | 76.26 |
| Total Debt | 479M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.14 |
| Book Value Per Share | 164.53 |
| 52-Week Change | -26.18 |
| 52-Week High | 355 |
| 52-Week Low | 246 |
| Moving Average 50 Days | 274.94 |
| Moving Average 200 Days | 290.08 |
| Average Volume | 102,163 |
| Shares Outstanding | 50.25M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 3.3 |
| Trailing Annual Dividend Yield | 1.25 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | March 30, 2020 |